Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Share Price    (AUBD)

Here is the latest stock price and chart of Aurobindo Pharma. For more details, see the Aurobindo Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Free Signup: Learn how India is poised to emerge as a global power

REFRESH
Live BSE Quotes Oct 28, 2020 (Close)
Price (Rs)775.95 Open (Rs) 799.00 High (Rs) 799.50 Low (Rs) 771.65
% Change-2.36 Volume 92,989 Value (Rs) 72,923,416 52-Week H/L 967.60 / 281.15
Live NSE Quotes Oct 28, 2020 (Close)
Price (Rs)776.30 Open (Rs) 794.30 High (Rs) 799.90 Low (Rs) 771.60
% Change-2.24 Volume 2,219,402 Value (Rs) 1,741,263,939 52-Week H/L 967.50 / 288.85
Change
1 Day
-2.36%
1 Month
-3.20%
3 Months
-1.92%
1 Year
64.43%
5 Years (CAGR)*
-1.84%
10 Years (CAGR)*
20.61%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 51.38 P/E Ratio (x) 15.10 Market Cap (Rs m) 454,061.89 P/BV (x) 3.27
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

AUROBINDO PHARMA Share Price Today:

AUROBINDO PHARMA last traded price was down 2.4% to Rs 776.0 on the BSE. On the NSE, AUROBINDO PHARMA last traded price was down 2.2% to Rs 776.3. The total volume of shares traded was 2.3 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 1.3%. And the benchmark S&P BSE SENSEX was at 39,922.5 (down 1.5%).

Over the last 30 days, the AUROBINDO PHARMA share price is down 3.2%. And over the last one year, AUROBINDO PHARMA share price is up 64.8%.



What else is happening in the markets today? Dig in...


Today's Market

5 Reasons Why Sensex Crashed 600 Points Today(Closing)

Indian share markets witnessed a sharp sell-off today and ended their session deep in the red.

Related Views On News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

Why ITC and not HUL is my Idea of a Good Investment Right Now Views On News (Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

PSU Banks Will Move Up Again (Profit Hunter)

Oct 27, 2020

My charts tell me PSU banks are set for a rebound.

Why India's Drone Revolution is a 4x Profit Opportunity (Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - ACTAVIS COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS